Table 1. miRNAs targeting Wnt antagonist in ovarian cancer.

Non-coding RNAs	Cancer type	Function	Reference
miR-92a-1	Epithelial Ovarian Cancer	Increased expression promotes oncogenic activation, & chemoresistance. Targets DKK1	(Chen et al., 2017)
miR-372		Increased expression downregulates DKK1 activation	(Guan et al., 2017)
miR-126–5p		Increased expression represses DKK3, & promote platinum resistance	(Wu et al., 2019)
miR-1180		Loss of tumour suppressor function, & promotes chemoresistance. Targets SFRP1	(Gu et al., 2019)
miR-1207		Promote cancer stem cell like fate & loss of tumour suppressor function. Targets SFRP1	(Wu et al., 2015)
miR-181a		Increased chemoresistance and cancer stemness. Targets SFRP4	(Nagaraj et al., 2021)